These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30587593)

  • 21. LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells.
    Yue Z; Yuan Z; Zeng L; Wang Y; Lai L; Li J; Sun P; Xue X; Qi J; Yang Z; Zheng Y; Fang Y; Li D; Siwko S; Li Y; Luo J; Liu M
    FASEB J; 2018 May; 32(5):2422-2437. PubMed ID: 29269400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of NUMB/NUMB isoforms in cancer stem cells.
    Choi HY; Seok J; Kang GH; Lim KM; Cho SG
    BMB Rep; 2021 Jul; 54(7):335-343. PubMed ID: 34078527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autocrine Semaphorin3A signaling is essential for the maintenance of stem-like cells in lung cancer.
    Yamada D; Takahashi K; Kawahara K; Maeda T
    Biochem Biophys Res Commun; 2016 Nov; 480(3):375-379. PubMed ID: 27769863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An alginate-based platform for cancer stem cell research.
    Qiao SP; Zhao YF; Li CF; Yin YB; Meng QY; Lin FH; Liu Y; Hou XL; Guo K; Chen XB; Tian WM
    Acta Biomater; 2016 Jun; 37():83-92. PubMed ID: 27109764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adipose-derived stem cells enhance human breast cancer growth and cancer stem cell-like properties through adipsin.
    Goto H; Shimono Y; Funakoshi Y; Imamura Y; Toyoda M; Kiyota N; Kono S; Takao S; Mukohara T; Minami H
    Oncogene; 2019 Feb; 38(6):767-779. PubMed ID: 30177835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NMI inhibits cancer stem cell traits by downregulating hTERT in breast cancer.
    Feng X; Xu X; Xiao X; Zou K; Yu W; Wu J; Tang R; Gao Y; Hao J; Zhao X; Liao Y; Chen Y; Huang W; Guo W; Kang L; Deng W
    Cell Death Dis; 2017 May; 8(5):e2783. PubMed ID: 28492540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytoprotective effect of neuropeptides on cancer stem cells: vasoactive intestinal peptide-induced antiapoptotic signaling.
    Sastry KS; Chouchane AI; Wang E; Kulik G; Marincola FM; Chouchane L
    Cell Death Dis; 2017 Jun; 8(6):e2844. PubMed ID: 28569785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells.
    Tang X; Li X; Li Z; Liu Y; Yao L; Song S; Yang H; Li C
    Tumour Biol; 2016 Oct; 37(10):13425-13433. PubMed ID: 27460092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic profiling of putative breast cancer stem cells from malignant pleural effusions.
    Tiran V; Stanzer S; Heitzer E; Meilinger M; Rossmann C; Lax S; Tsybrovskyy O; Dandachi N; Balic M
    PLoS One; 2017; 12(4):e0175223. PubMed ID: 28423035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
    Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
    Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of chromatin accessibility domains in human breast cancer stem cells.
    Hardy K; Wu F; Tu W; Zafar A; Boulding T; McCuaig R; Sutton CR; Theodoratos A; Rao S
    Nucleus; 2016; 7(1):50-67. PubMed ID: 26962893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer.
    Wei W; Tweardy DJ; Zhang M; Zhang X; Landua J; Petrovic I; Bu W; Roarty K; Hilsenbeck SG; Rosen JM; Lewis MT
    Stem Cells; 2014 Oct; 32(10):2571-82. PubMed ID: 24891218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

  • 34. Propofol Reduced Mammosphere Formation of Breast Cancer Stem Cells via PD-L1/Nanog
    Zhang X; Li F; Zheng Y; Wang X; Wang K; Yu Y; Zhao H
    Oxid Med Cell Longev; 2019; 2019():9078209. PubMed ID: 30906504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KRT19 directly interacts with β-catenin/RAC1 complex to regulate NUMB-dependent NOTCH signaling pathway and breast cancer properties.
    Saha SK; Choi HY; Kim BW; Dayem AA; Yang GM; Kim KS; Yin YF; Cho SG
    Oncogene; 2017 Jan; 36(3):332-349. PubMed ID: 27345400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling of Cancer Stem Cell State Transitions Predicts Therapeutic Response.
    Sehl ME; Shimada M; Landeros A; Lange K; Wicha MS
    PLoS One; 2015; 10(9):e0135797. PubMed ID: 26397099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
    Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
    Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer stem cell (a)symmetry & plasticity: Tumorigenesis and therapy relevance.
    Najafi M; Mortezaee K; Ahadi R
    Life Sci; 2019 Aug; 231():116520. PubMed ID: 31158379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA-Hh Strengthen Cancer Stem Cells Generation in Twist-Positive Breast Cancer via Activation of Hedgehog Signaling Pathway.
    Zhou M; Hou Y; Yang G; Zhang H; Tu G; Du YE; Wen S; Xu L; Tang X; Tang S; Yang L; Cui X; Liu M
    Stem Cells; 2016 Jan; 34(1):55-66. PubMed ID: 26418365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PGE
    Lin MC; Chen SY; He PL; Herschman H; Li HJ
    Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.